Catalyst Wire Dossier Catalyst Wire Dossier

GSK RSV vaccine

respiratory syncytial virus vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK RSV vaccine, covering 2023-08-04 to 2023-08-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above [Phase 3]

See pricing